Oxford Asset Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-20,269
| Closed | -$187K | – | 1499 |
|
|
2019
Q4 | $187K | Buy |
+20,269
| New | +$187K | 0.01% | 1563 |
|
|
2018
Q4 | – | Sell |
-177,372
| Closed | -$2.62M | – | 2195 |
|
|
2018
Q3 | $2.62M | Buy |
177,372
+47,963
| +37% | +$710K | 0.05% | 514 |
|
|
2018
Q2 | $2.2M | Buy |
129,409
+42,581
| +49% | +$725K | 0.04% | 608 |
|
|
2018
Q1 | $1.99M | Sell |
86,828
-112,053
| -56% | -$2.57M | 0.04% | 581 |
|
|
2017
Q4 | $5.2M | Buy |
+198,881
| New | +$5.2M | 0.11% | 218 |
|
|
2017
Q3 | – | Sell |
-19,711
| Closed | -$275K | – | 1761 |
|
|
2017
Q2 | $275K | Buy |
19,711
+5,835
| +42% | +$81.4K | 0.01% | 1281 |
|
|
2017
Q1 | $237K | Buy |
+13,876
| New | +$237K | 0.01% | 1271 |
|
|
2016
Q4 | – | Sell |
-49,104
| Closed | -$496K | – | 891 |
|
|
2016
Q3 | $496K | Sell |
49,104
-146,280
| -75% | -$1.48M | 0.02% | 618 |
|
|
2016
Q2 | $2.19M | Sell |
195,384
-13,510
| -6% | -$152K | 0.07% | 350 |
|
|
2016
Q1 | $2.85M | Sell |
208,894
-105,044
| -33% | -$1.43M | 0.08% | 293 |
|
|
2015
Q4 | $5.99M | Buy |
+313,938
| New | +$5.99M | 0.14% | 146 |
|